Table 2.
Prevalence of cytologic diagnosis of uterine cervix according to the type of medical institution
| Cytology | University hospital | Commercial laboratory | General hospital | Total |
|---|---|---|---|---|
| Unsatisfactory | 5,010 (0.5) | 30,271 (0.7) | 5,421 (0.7) | 40,702 (0.6) |
| Negative | 872,873 (93.6) | 4,382,832 (94.7) | 741,720 (95.5) | 5,997,425 (94.6) |
| ASCUS | 29,421 (3.2) | 171,549 (3.7) | 20,224 (2.6) | 221,194 (3.5) |
| ASC-H | 3,792 (0.4) | 6,640 (0.1) | 1,504 (0.2) | 11,936 (0.2) |
| LSIL | 13,262 (1.4) | 28,667 (0.6) | 5,253 (0.7) | 47,182 (0.7) |
| HSIL | 5,243 (0.6) | 6,010 (0.1) | 1,833 (0.2) | 13,086 (0.2) |
| Squamous cell carcinoma | 890 (0.1) | 500 (< 0.1) | 246 (< 0.1) | 1,636 (< 0.1) |
| AGC | 1,055 (0.1) | 2,350 (0.1) | 507 (0.1) | 3,912 (0.1) |
| AGC, favor neoplastic | 195 (< 0.1) | 292 (< 0.1) | 74 (< 0.1) | 561 (< 0.1) |
| Adenocarcinoma in situ | 51 (< 0.1) | 4 (< 0.1) | 19 (< 0.1) | 74 (< 0.1) |
| Adenocarcinoma | 348 (< 0.1) | 65 (< 0.1) | 64 (< 0.1) | 477 (< 0.1) |
| Others | 56 (< 0.1) | 628 (< 0.1) | 13 (< 0.1) | 697 (< 0.1) |
| Total | 932,196 (100) | 4,629,808 (100) | 776,878 (100) | 6,338,882 (100) |
Values are presented as number (%).
ASCUS, atypical squamous cells of undetermined significance; ASC-H, atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; AGC, atypical glandular cells.